Page 123 - Read Online

Page 16 of 20 Vidoni et al. J Cancer Metastasis Treat 2021;7:4 I http://dx.doi.org/10.20517/2394-4722.2020.95

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflict of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2021.

REFERENCES
1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74.
2. Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab 2016;23:27-47.
3. Hui L, Chen Y. Tumor microenvironment: sanctuary of the devil. Cancer Lett 2015;368:7-13.
4. Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer 2017;17:528-42.
5. Han Y, Fan S, Qin T, et al. Role of autophagy in breast cancer and breast cancer stem cells (Review). Int J Oncol 2018;52:1057-70.
6. Romero MA, Bayraktar Ekmekcigil O, Bagca BG, et al. Role of autophagy in breast cancer development and progression: opposite sides
of the same coin. In: Ahmad A, editor. Breast cancer metastasis and drug resistance. Cham: Springer International Publishing; 2019. p.
65-73.
7. Lisiak N, Toton E, Rybczynska M. Autophagy as a potential therapeutic target in breast cancer treatment. Curr Cancer Drug Targets
2018;18:629-39.
8. Peracchio C, Alabiso O, Valente G, Isidoro C. Involvement of autophagy in ovarian cancer: a working hypothesis. J Ovarian Res
2012;5:22.
9. Thuwajit C, Ferraresi A, Titone R, Thuwajit P, Isidoro C. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts
in ovarian cancer progression: autophagy plays a role. Med Res Rev 2018;38:1235-54.
10. Mattoscio D, Medda A, Chiocca S. Human papilloma virus and autophagy. Int J Mol Sci 2018;19:1775.
11. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability--an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010;11:220-8.
12. Guo M, Peng Y, Gao A, Du C, Herman JG. Epigenetic heterogeneity in cancer. Biomark Res 2019;7:23.
13. Garcia-Gomez A, Rodríguez-Ubreva J, Ballestar E. Epigenetic interplay between immune, stromal and cancer cells in the tumor
microenvironment. Clin Immunol 2018;196:64-71.
14. Yamashita S, Kishino T, Takahashi T, et al. Genetic and epigenetic alterations in normal tissues have differential impacts on cancer risk
among tissues. Proc Natl Acad Sci U S A 2018;115:1328-33.
15. Ferlay J, Steliarova-Foucher E, Antoni S, Masuyer E. Data processing. IARC Sci Publ 2014;(164 Pt 1):107-11.
16. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68:394-424.
17. Waks AG, Winer EP. Breast cancer treatment: a review. JAMA-J AM MED ASSOC 2019;321:288-300.
18. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938-48.
19. Joshi H, Press MF. Molecular oncology of breast cancer. The Breast. Elsevier; 2018. p. 282-307.e5.
20. Tao ZQ, Shi AM, Lu CT, Song T, Zhang ZG, Zhao J. Breast Cancer: Epidemiology and Etiology. Cell Biochem Biophys 2015;72:333-8.
21. Mahdavi M, Nassiri M, Kooshyar MM, et al. Hereditary breast cancer; Genetic penetrance and current status with BRCA. J Cell Physiol
2019;234:5741-50.
22. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med 2017;14:9-32.
23. Ren F, Shen J, Shi H, Hornicek FJ, Kan Q, Duan Z. Novel mechanisms and approaches to overcome multidrug resistance in the treatment
of ovarian cancer. Biochim Biophys Acta 2016;1866:266-75.
24. Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis: type I and type II. Biomed Res Int 2014;2014:934261.
25. Toss A, Tomasello C, Razzaboni E, et al. Hereditary ovarian cancer: not only BRCA 1 and 2 genes. Biomed Res Int2015;2015:11.
26. Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs 2019;35:151-6.
27. Chandra A, Pius C, Nabeel M, et al. Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med